Home › Funds › SUPERSTRING CAPITAL MANAGEMENT LP › SION

SUPERSTRING CAPITAL MANAGEMENT LP position in SION

SIONNA THERAPEUTICS INC · Health Care

SUPERSTRING CAPITAL MANAGEMENT LP reported holding 63,156 shares of SION (SIONNA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$2.8M, representing 1.75% of its reported portfolio and ranking #21 among its reported holdings. SUPERSTRING CAPITAL MANAGEMENT LP has disclosed SION holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)63.16K sh
Reported value held$2.78M
Portfolio Weight1.75%
First reportedQ4 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SUPERSTRING CAPITAL MANAGEMENT LP's SION position evolved

SUPERSTRING CAPITAL MANAGEMENT LP first disclosed a stake in SION in Q4 2025 at 180,593 shares (US$7.4M). Across 3 filings, SUPERSTRING CAPITAL MANAGEMENT LP increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 63,156 shares valued at US$2.8M — a reduction of -77,868 shares quarter over quarter.. Notable position changes include a 55% trim in Q2 2026 (shares fell 88% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 180.59K $7.43M New
Q1 2026 141.02K $5.65M Reduce
Q2 2026 63.16K $2.78M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SION and 13F data

SION (SIONNA THERAPEUTICS INC) is a Health Care company. 86 other funds we track also report a position in SION — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$435.7M), TPG GP A, LLC (US$285.7M), Atlas Venture Life Science Advisors, LLC (US$131.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SION

All SION fund holders →

FAQ

How long has SUPERSTRING CAPITAL MANAGEMENT LP held SION?

SUPERSTRING CAPITAL MANAGEMENT LP has disclosed SION holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is SUPERSTRING CAPITAL MANAGEMENT LP's current position in SION?

As of Q2 2026, SUPERSTRING CAPITAL MANAGEMENT LP holds 63.16K shares of SION (SIONNA THERAPEUTICS INC), valued at $2.78M, representing 1.75% of its reported portfolio and ranking #21.

Has SUPERSTRING CAPITAL MANAGEMENT LP been buying or selling SION?

In the latest 13F filing (Q2 2026), SUPERSTRING CAPITAL MANAGEMENT LP reduced its position in SION.

Which other funds hold SION?

Other major institutional holders of SION include RA CAPITAL MANAGEMENT, L.P., TPG GP A, LLC, Atlas Venture Life Science Advisors, LLC, among 86 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.